Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Identification of biomarkers of chronic kidney disease among kidney-derived proteins

Fig. 2

Usefulness of C1q as a biomarker of chronic kidney disease (CKD) in mice. a Serum concentrations of C1q in streptozocin (STZ)-induced diabetic and vehicle control mice were examined by ELISA; the mean value was significantly higher in the diabetic mice. In each mouse, the serum C1q concentration was correlated with the b blood glucose level and c amount of urinary protein. d Serum concentrations of C1q in unilateral ureteral obstruction (UUO) and sham-operated control mice were examined by ELISA; the mean value did not differ between groups. Data are expressed as means ± S.E.M. (n = 4–6). *, P < 0.05 (t-test) compared with value for controls

Back to article page